Listing summary

We ran a consultation to hear researchers’ views on the challenges and opportunities in clinical trial data sharing.

English
Standfirst

We want to make it easier for researchers to share and re-use clinical trial data. Together with Cancer Research UK, the Medical Research Council and the Bill and Melinda Gates Foundation, we ran a consultation to hear researchers’ views on current barriers and opportunities. 

Published date
Content
Group
Group title
Key findings
Admin title
Key findings
Group
Body
  • Guidance and support: researchers need better guidance and support to share data, including training on how to de-identify data.
  • Standards: the research community needs to agree on universal standards, including data and meta-data standards, and acceptable levels of re-identification risk.
  • Cost: funders should cover the costs of sharing data, including data preparation and use of access committees, catalogues and repositories. It should be clear how researchers can ask for these costs. 
  • Recognition and incentives: funders should recognise data sharing more explicitly to incentivise researchers, and demonstrate that they value data as a research output. 
  • Principles and policies: we're committed to the FAIR principles and are signatories of the San Francisco Declaration on Research Assessment (DORA). We’ll continue to reflect this commitment in our funding policies. 
Group title
More information
Admin title
More information
Group
Body
Meta title
Clinical trial data sharing: what we’ve heard from researchers
Published on
Meta description
[Summary] We ran a consultation to hear researchers’ views on the challenges and opportunities in clinical trial data sharing.
Banner styling
Banner with image above title
Exclude from listings
Off
Add noindex
Off